Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN

No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015

(2020) Christine Verdon et al.   INFLAMMATORY BOWEL DISEASES

Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn’s Disease: Results From a Large Electronic Medical Record-derived Cohort

(2020) Jacob A Kurowski et al.   INFLAMMATORY BOWEL DISEASES

Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn’s Disease: A Population-based Cohort Study

(2020) P W Jenkinson et al.   Journal of Crohns & Colitis

Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964–2014

(2019) Ola Olén et al.   GUT

Decreasing Trends in Intestinal Resection and Re-Resection in Crohnʼs Disease

(2019) Evelien M. J. Beelen et al.   ANNALS OF SURGERY

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study

(2019) Sanjay K Murthy et al.   GUT

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

(2019) Joana Torres et al.   Journal of Crohns & Colitis

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

(2018) Johan Burisch et al.   GUT

Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study

(2018) Mira Y Friedman et al.   Clinical Epidemiology

Hospitalizations for Crohn’s Disease — United States, 2003–2013

(2017) Christopher A. Malarcher et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

(2016) E. J. Mao et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort

(2016) Steven F G Jeuring et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn’s Disease

(2016) Michael Due Larsen et al.   Journal of Crohns & Colitis

Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease

(2015) S. C. Shah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

(2014) F.M. Ruemmele et al.   Journal of Crohns & Colitis

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

(2012) Christina Ha et al.   Clinical Gastroenterology and Hepatology

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

(2012) Mirthe Emilie van der Valk et al.   GUT

Outcomes of Patients With Crohn's Disease Improved From 1988 to 2008 and Were Associated With Increased Specialist Care

(2011) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY